

Author: Prasad Roopa Gladman Dafna
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.13, Iss.2, 2004-02, pp. : 139-150
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Adalimumab an ADEPT treatment for psoriatic arthritis
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :




Psoriatic arthritis: current therapy and future directions
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 13, 2013-09 ,pp. :


Expert Opinion on Investigational Drugs, Vol. 9, Iss. 7, 2000-07 ,pp. :